Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

CCL1 As a Biomarker of Engraftment Syndrome of Hematological Stem Cell Transplantation

Hiroaki Maki, Akira Honda, Yosuke Masamoto, Mineo Kurokawa

Blood (2023) 142 (Supplement 1): 6788.

https://doi.org/10.1182/blood-2023-185908

Published: 2023

Journal Articles

Gene Panels for Intraocular Lymphoma Can Overcome Diagnostic Difficulties and Enable Precision Medicine

Kazuki Taoka, Arika Shimura-Nukina, Akira Honda, Yosuke Masamoto, Mineo Kurokawa

Blood (2023) 142 (Supplement 1): 5030.

https://doi.org/10.1182/blood-2023-187872

Published: 2023

Journal Articles

Novel Recurrent Mutations in Eldheim-Chester Disease Patients Identified By Whole Exome Sequencing and Whole Genome Sequencing

Yu Oyama, Akira Honda, Kensuke Matsuda, Hideaki Mizuno, Kazuki Taoka, Mineo Kurokawa

Blood (2021) 138 (Supplement 1): 3123.

https://doi.org/10.1182/blood-2021-149864

Published: 2021

Journal Articles

Novel Prediction Models for Myelodysplastic Syndromes Using Machine Learning

Kazuki Taoka, Ayumu Tsubosaka, Kumi Nakazaki, Akira Honda, Hiroaki Maki, Mineo Kurokawa

Blood (2021) 138 (Supplement 1): 1939.

https://doi.org/10.1182/blood-2021-151759

Published: 2021

Journal Articles

Intrapatient Complex Transcriptional Responses to Conventional Chemotherapy in Relapsed Acute Myeloid Leukemia Revealed By Single Cell RNA-Seq Analysis

Hideaki Mizuno, Akira Honda, Mineo Kurokawa

Blood (2021) 138 (Supplement 1): 1179.

https://doi.org/10.1182/blood-2021-153848

Published: 2021

Journal Articles

Prognostic Factors of Idiopathic Hypereosinophilic Syndrome: A Nationwide Survey in Japan

Akira Honda, Kazuhiro Toyama, Yu Oyama, Kensuke Matsuda, Hideaki Mizuno, Akiko M Saito, Yoshio Katayama, Norio Komatsu, Mineo Kurokawa

Blood (2021) 138 (Supplement 1): 4192.

https://doi.org/10.1182/blood-2021-147609

Published: 2021

Journal Articles

Risk of Febrile Neutropenia in Very Elderly Patients Aged ≥80 Years Who Received R-CHOP Regimen: A Nationwide Analysis in Japan

Kensuke Matsuda, Taisuke Jo, Arika Nukina Shimura, Akira Honda, Yosuke Masamoto, Hideo Yasunaga, Mineo Kurokawa

Blood (2021) 138 (Supplement 1): 2530.

https://doi.org/10.1182/blood-2021-144998

Published: 2021

Journal Articles

Predictors of Glucocorticoid Responsiveness in Multicentric Castleman's Disease

Kazutoshi Ebisawa, MD, Arika Nukina Shimura, MD, Akira Honda, MD PhD, Yosuke Masamoto, MD PhD, Fumio Nakahara, MD PhD, Mineo Kurokawa, MD PhD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-136469

Published: 2020

Journal Articles

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Kazuhiro Toyama, MD PhD, Toshiaki Takezaki, MD, Akira Honda, MD PhD, Yasunori Kogure, MD PhD, Akira Chiba, MD, Fumihiko Nakamura, MD PhD, Kumi Nakazaki, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 5242.

https://doi.org/10.1182/blood-2019-124597

Published: 2019

Journal Articles

Bortezomib Overcomes Poor Prognosis Conferred By High Sictp in Untreated Plasma Cell Disorders

Akira Honda, MD PhD, Yu Oyama, MD, Kazuhiro Toyama, MD PhD, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 5492.

https://doi.org/10.1182/blood-2019-129324

Published: 2019

Journal Articles

Identification of Somatic Mutation Contributing to Chemotherapy Resistance in Acute Myeloid Leukemia

Akira Honda, MD, PhD, Junji Koya, MD, PhD, Akihide Yoshimi, MD PhD, Keisuke Kataoka, MD PhD, Shunya Arai, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 600.

https://doi.org/10.1182/blood.V128.22.600.600

Published: 2016

Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

Masashi Miyauchi, MD, PhD, Shunya Arai, MD, PhD, Akira Honda, MD PhD, Sho Yamazaki, MD, PhD, Keisuke Kataoka, MD PhD, Akihide Yoshimi, MD, PhD, Kazuki Taoka, MD, PhD, Keiki Kumano, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 1878.

https://doi.org/10.1182/blood.V128.22.1878.1878

Published: 2016

Journal Articles

The Nationwide Study of Erdheim-Chester Disease in Japan

Mizuki Ogura, MD, PhD, Takashi Toya, MD, PhD, Akihide Yoshimi, MD, PhD, Aya Shinozaki Ushiku, MD, PhD, Akira Honda, MD, PhD, Toyama Kazuhiro, MD, PhD, Kenjiro Honda, MD, PhD, Yasuhito Nannya, MD, PhD, Yusuke Shinoda, MD, PhD, Akiko M. Saito, MD PhD, Takashi Ogura, MD, Ichiro Katayama, MD, PhD, Kiyoshi Miyagawa, MD, PhD, Masaomi Nangaku, MD, PhD, Masashi Fukayama, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 4879.

https://doi.org/10.1182/blood.V128.22.4879.4879

Published: 2016

Journal Articles

Serum LDH Is Useful to Predict Prognosis for Intermediate-Risk Myelodysplastic Syndrome

Kiyomi Morita, MD, Shunya Arai, MD, PhD, Yasunori Kogure, MD, Akira Honda, MD, Kumi Nakazaki, MD, PhD, Mineo Kurokawa, MD

Blood (2015) 126 (23): 5255.

https://doi.org/10.1182/blood.V126.23.5255.5255

Published: 2015

NARROW

CCL1 As a Biomarker of Engraftment Syndrome of Hematological Stem Cell Transplantation

Gene Panels for Intraocular Lymphoma Can Overcome Diagnostic Difficulties and Enable Precision Medicine

Novel Recurrent Mutations in Eldheim-Chester Disease Patients Identified By Whole Exome Sequencing and Whole Genome Sequencing

Novel Prediction Models for Myelodysplastic Syndromes Using Machine Learning

Intrapatient Complex Transcriptional Responses to Conventional Chemotherapy in Relapsed Acute Myeloid Leukemia Revealed By Single Cell RNA-Seq Analysis

Prognostic Factors of Idiopathic Hypereosinophilic Syndrome: A Nationwide Survey in Japan

Risk of Febrile Neutropenia in Very Elderly Patients Aged ≥80 Years Who Received R-CHOP Regimen: A Nationwide Analysis in Japan

Predictors of Glucocorticoid Responsiveness in Multicentric Castleman's Disease

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Bortezomib Overcomes Poor Prognosis Conferred By High Sictp in Untreated Plasma Cell Disorders

Identification of Somatic Mutation Contributing to Chemotherapy Resistance in Acute Myeloid Leukemia

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

The Nationwide Study of Erdheim-Chester Disease in Japan

Serum LDH Is Useful to Predict Prognosis for Intermediate-Risk Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only